Perrigo Co. Plc Hits New 52-Week Low at USD 20.18

Perrigo Co. Plc, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 20.18 on November 4, 2025. This marks a significant decline, reflecting a one-year performance drop of 25.94%, contrasting sharply with the S&P 500's gain of 19.89% during the same period.
The company's financial metrics indicate ongoing challenges. With a market capitalization of USD 3,072 million, Perrigo's price-to-book ratio stands at 0.69, suggesting that the stock is trading below its book value. The return on equity is relatively low at 0.37%, and the dividend yield is modest at 0.04%.

Recent financial results have shown a net profit loss of USD 67.46 million over the past nine months, a staggering decline of 202.37%. Additionally, the pre-tax profit for the latest quarter fell by 90.52%. The rising raw material costs, which increased by 7.52% year-over-year, further complicate the company's financial landscape.

Overall, Perrigo's consistent underperformance against market benchmarks over the last three years highlights the challenges it faces in the current economic environment.